Finance

Lists
060590:KOSDAQ
CTC Bio Inc
2 585,00 KRW
-1,90%
(-50,00) 1D
30 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 060590...
Open
2 610 KRW
High
2 645 KRW
Low
2 585 KRW
Mkt. cap
62,51 მლრდ.
Avg. vol.
38,49 ათ.
Volume
23,55 ათ.
P/E ratio
8,22
52-wk high
5 610 KRW
52-wk low
2 570 KRW
EPS
314 KRW
Shares outstanding
24,18 მლნ.
No. of employees
226
Open
2 610 KRW
High
2 645 KRW
Low
2 585 KRW
Mkt. cap
62,51 მლრდ.
Avg. vol.
38,49 ათ.
Volume
23,55 ათ.
P/E ratio
8,22
52-wk high
5 610 KRW
52-wk low
2 570 KRW
EPS
314 KRW
Shares outstanding
24,18 მლნ.
No. of employees
226
News stories
From web sources and news partners
CNBC
CNBC
·
1 საათის წინ
Anthropic's path to the Nasdaq just got a lot bumpier
CEOWORLD magazine
CEOWORLD magazine
·
1 წუთის წინ
Chinese Billionaire Zhou Yahui’s OPay Rings the NYSE Bell, Then Cancels Its $4 Billion Debut
Seeking Alpha
Seeking Alpha
·
5 წუთის წინ
Okta to replace Kenvue in S&P 500 (OKTA:NASDAQ)
Bloomberg
Bloomberg
·
16 საათის წინ
AI Dip-Buyers Gored as Selling Spasm Caps Third Week of Losses
About CTC Bio Inc
CEO-
Employees226
Founded1993
Headquarters-
SectorPharmaceutical industry
Websitectcbio.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
31,80 მლრდ.
31,62 მლრდ.
34,44 მლრდ.
33,69 მლრდ.
Cost of goods sold
19,35 მლრდ.
18,91 მლრდ.
20,10 მლრდ.
20,42 მლრდ.
Cost of revenue
19,35 მლრდ.
18,91 მლრდ.
20,10 მლრდ.
20,42 მლრდ.
Research and development expenses
427,62 მლნ.
482,35 მლნ.
205,61 მლნ.
198,23 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,33 მლრდ.
10,29 მლრდ.
9,30 მლრდ.
8,87 მლრდ.
Operating expense
11,00 მლრდ.
11,20 მლრდ.
9,74 მლრდ.
9,48 მლრდ.
Total operating expenses
30,35 მლრდ.
30,11 მლრდ.
29,84 მლრდ.
29,89 მლრდ.
Operating income
1,45 მლრდ.
1,51 მლრდ.
4,60 მლრდ.
3,79 მლრდ.
Other non operating income
-33,35 მლნ.
-91,96 მლნ.
-55,25 მლნ.
-271,27 ათ.
EBT including unusual items
1,01 მლრდ.
-220,58 მლნ.
4,46 მლრდ.
3,49 მლრდ.
EBT excluding unusual items
943,91 მლნ.
-84,63 მლნ.
4,38 მლრდ.
3,38 მლრდ.
Income tax expense
656,08 მლნ.
-1,34 მლრდ.
955,92 მლნ.
887,77 მლნ.
Effective tax rate
64,69%
607,65%
21,45%
25,44%
Other operating expenses
109,16 მლნ.
92,32 მლნ.
34,12 მლნ.
202,89 მლნ.
Net income
310,40 მლნ.
1,10 მლრდ.
3,50 მლრდ.
2,60 მლრდ.
Net profit margin
0,98%
3,48%
10,16%
7,72%
Earnings per share
-
-
-
-
Interest and investment income
60,95 მლნ.
94,40 მლნ.
73,22 მლნ.
73,88 მლნ.
Interest expense
-604,79 მლნ.
-569,99 მლნ.
-553,03 მლნ.
-563,90 მლნ.
Net interest expenses
-543,84 მლნ.
-475,58 მლნ.
-479,80 მლნ.
-490,02 მლნ.
Depreciation and amortization charges
216,74 მლნ.
200,89 მლნ.
174,51 მლნ.
175,71 მლნ.
EBITDA
3,07 მლრდ.
3,11 მლრდ.
6,17 მლრდ.
5,38 მლრდ.
Gain or loss from assets sale
-94,40 მლნ.
-132,54 მლნ.
-78,68 მლნ.
-117,11 მლნ.
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები